India’s drug-control strategy is entering a more intelligence-led phase. While drug seizures remain an important enforcement measure, the focus is increasingly shifting toward dismantling the networks that enable trafficking — from entry points and distribution channels to financial flows and digital infrastructure.
At the 3rd National Conference of Anti-Narcotics Task Force (ANTF) Heads in September 2026, the Union Home Minister emphasized the need to move from “Seizure to End of Network” and from “Case to Conviction.” The government has also set 31 December 2029 as the target for collectively uprooting the drug trade from India.
The shift comes as trafficking networks become increasingly complex. Synthetic drugs, precursor diversion, clandestine laboratories, darknet platforms, cryptocurrency, drones, courier networks and international trafficking routes are creating new challenges for traditional enforcement models.
Recent enforcement trends indicate that drug-control activity is increasingly being measured through investigation and action against offenders and networks, rather than only by the quantity of drugs intercepted.
Between 2023 and 2025, drug seizures declined, while registered cases and arrests increased. This divergence suggests that enforcement agencies are increasingly pursuing intelligence-led investigations that can involve multiple individuals, trafficking links and distribution channels without necessarily resulting in larger physical seizures.
The trend does not, by itself, indicate changes in drug consumption or availability. Instead, it highlights a broader change in how enforcement activity is being conducted and measured.
Drug trafficking networks depend on financial flows to sustain procurement, transportation, distribution and expansion. Consequently, following and disrupting illicit proceeds is becoming an increasingly important component of India’s drug-control strategy.
Financial investigation cases involving frozen or seized property more than doubled between 2023 and 2025, while the value of such property also increased substantially. This reflects greater emphasis on identifying the financial infrastructure supporting trafficking operations.
The approach effectively expands enforcement from seizing the product to targeting the economics of the network.
Synthetic drugs are creating a different set of challenges for enforcement agencies. Unlike traditional narcotics, synthetic substances can be produced closer to consumer markets using precursor chemicals and relatively small clandestine laboratories.
Recent enforcement activity has highlighted growing seizures of synthetic stimulants such as ATS and Mephedrone, alongside the dismantling of clandestine laboratories and interception of precursor chemicals.
This is shifting attention toward the entire production ecosystem — including precursor sourcing, laboratory infrastructure, chemical supply chains and technical expertise — rather than focusing only on the finished drug.
Drug trafficking is also becoming increasingly technology-enabled. Darknet marketplaces, cryptocurrency, encrypted communications, digital payments and drone-based deliveries can provide traffickers with additional layers of anonymity and flexibility.
SThe emergence of these channels is making conventional physical surveillance less sufficient on its own. Enforcement agencies increasingly need capabilities that combine digital intelligence, financial investigation, forensic analysis and physical surveillance.
The challenge is therefore no longer limited to identifying where drugs are moving, but also understanding how trafficking networks communicate, transact and coordinate.
India’s drug-control challenge extends across multiple trafficking channels, including land borders, maritime routes, courier and postal networks and emerging drone-based routes.
This diversification makes it increasingly difficult to address trafficking through isolated interdictions. A single seizure may represent only one part of a wider supply chain involving suppliers, intermediaries, transporters, financiers and local distributors.
The emerging enforcement model therefore places greater emphasis on backward and forward investigations to connect individual cases with the wider network behind them.
The next phase of drug control is also expected to become more geographically targeted. The 2026–2029 roadmap envisages classifying districts according to their role in the trafficking ecosystem, including manufacturing or entry locations, transportation corridors and consumption districts.
This approach can help enforcement agencies prioritize resources according to local trafficking patterns rather than applying a uniform strategy across the country.
It also increases the importance of coordination between national agencies, state ANTFs, police, customs, financial investigation agencies and other stakeholders.
The shift toward network disruption does not replace demand reduction and rehabilitation. Prevention, awareness and community-level intervention remain important components of India’s wider narcotics-control framework.
The government’s roadmap includes initiatives to expand community participation and drug-awareness efforts through the Nasha Mukt Bharat Abhiyaan, alongside greater engagement with educational institutions and local stakeholders.
This reflects the broader objective of addressing both sides of the drug-control challenge: disrupting supply networks while reducing vulnerability to drug use.
India’s drug-control landscape is therefore moving from a predominantly seizure-centric approach toward a network-disruption model.
The objective is increasingly to connect individual seizures and cases with the broader ecosystem behind trafficking — identifying the people, routes, money, technology and infrastructure that allow networks to operate.
For enforcement agencies, this will increase the importance of intelligence sharing, financial forensics, digital investigation, precursor monitoring, specialized technology, forensic capabilities and inter-agency coordination.
The effectiveness of drug control will increasingly depend not only on how much is seized, but on how effectively the network behind the seizure is dismantled.
AT HBGTM Insights, we help organizations assess evolving regulatory, market and industry dynamics to identify risks, opportunities and strategic implications.
Our research capabilities can support organizations in evaluating policy developments, regulatory landscapes, emerging risks, technology-led disruption, industry dynamics and market opportunities across complex and evolving sectors.
As India’s drug-control framework becomes increasingly intelligence-led and network-focused, understanding how enforcement priorities, technology, regulation and institutional capabilities are evolving will be critical for stakeholders assessing the broader implications of this transition.
Visit www.hbginsights.com to explore how research-driven intelligence platforms can unlock value, strengthen trust, and drive long-term growth.
Discover More
Partha has 20+ years of experience delivering impactful, data-driven solutions to clients across business and consumer segments. He specializes in strategic and competitive analysis, helping clients win in complex marketplaces. Before joining HBGTM Insights, Partha held leadership roles at AMI-Partners (APAC), IMaCS, Annik Technology, and has worked with ACNielsen, TNS, and Vodafone. He holds an M.Sc. in Statistics & Econometrics from the University of Calcutta and an MBA in Marketing from NPC-Delhi, and has been widely featured in leading publications like Business Standard, Economic Times, CXO, The Telegraph, CRN etc.
Know More